Quick Answer
Organon & Co. reported R&D Expense of $443.00 million for fiscal year 2021.
Organon & Co. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $443.00M | +111.0% |
| 2020 | $210.00M | -4.5% |
| 2019 | $220.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $96.00M | +43.3% | -13.5% |
| September 30, 2021 | $111.00M | +105.6% | +46.1% |
| June 30, 2021 | $76.00M | +49.0% | +13.4% |
| March 31, 2021 | $67.00M | +48.9% | +24.1% |
| September 30, 2020 | $54.00M | — | +5.9% |
| June 30, 2020 | $51.00M | — | +13.3% |
| March 31, 2020 | $45.00M | — | — |
- Organon & Co. showed an increase of +111.0% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2021 period, Organon & Co.’s r&d expense has grown by 101.4% (from $220.00 million to $443.00 million).
- The most recent figure is from Organon & Co.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 21, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: